CanSino Biologics Inc. (HKG:6185)

CanSino Biologics Statistics

Total Valuation

HKG:6185 has a market cap or net worth of HKD 16.03 billion. The enterprise value is 14.53 billion.

Market Cap	16.03B
Enterprise Value	14.53B

Important Dates

The last earnings date was Monday, October 27, 2025.

Earnings Date	Oct 27, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:6185 has 247.04 million shares outstanding. The number of shares has decreased by -1.66% in one year.

Current Share Class	132.67M
Shares Outstanding	247.04M
Shares Change (YoY)	-1.66%
Shares Change (QoQ)	-40.81%
Owned by Insiders (%)	31.39%
Owned by Institutions (%)	7.15%
Float	159.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	67.67
PS Ratio	15.09
PB Ratio	2.97
P/TBV Ratio	3.09
P/FCF Ratio	n/a
P/OCF Ratio	95.45
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-93.62
EV / Sales	13.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-84.91

Financial Position

The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.29.

Current Ratio	3.62
Quick Ratio	3.24
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	-9.10
Interest Coverage	-4.67

Financial Efficiency

Return on equity (ROE) is -2.84% and return on invested capital (ROIC) is -2.11%.

Return on Equity (ROE)	-2.84%
Return on Assets (ROA)	-1.87%
Return on Invested Capital (ROIC)	-2.11%
Return on Capital Employed (ROCE)	-3.68%
Revenue Per Employee	961,196
Profits Per Employee	-140,481
Employee Count	1,105
Asset Turnover	0.13
Inventory Turnover	0.71

Taxes

Income Tax	-5.44M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +58.15% in the last 52 weeks. The beta is 1.27, so HKG:6185's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	+58.15%
50-Day Moving Average	49.05
200-Day Moving Average	38.62
Relative Strength Index (RSI)	49.48
Average Volume (20 Days)	968,047

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:6185 had revenue of HKD 1.06 billion and -155.23 million in losses. Loss per share was -0.64.

Revenue	1.06B
Gross Profit	788.53M
Operating Income	-249.90M
Pretax Income	-160.67M
Net Income	-155.23M
EBITDA	-92.30M
EBIT	-249.90M
Loss Per Share	-0.64

Balance Sheet

The company has 3.05 billion in cash and 1.56 billion in debt, giving a net cash position of 1.49 billion or 6.04 per share.

Cash & Cash Equivalents	3.05B
Total Debt	1.56B
Net Cash	1.49B
Net Cash Per Share	6.04
Equity (Book Value)	5.39B
Book Value Per Share	29.52
Working Capital	3.12B

Cash Flow

In the last 12 months, operating cash flow was 167.90 million and capital expenditures -339.05 million, giving a free cash flow of -171.16 million.

Operating Cash Flow	167.90M
Capital Expenditures	-339.05M
Free Cash Flow	-171.16M
FCF Per Share	-0.69

Margins

Gross margin is 74.24%, with operating and profit margins of -23.53% and -14.62%.

Gross Margin	74.24%
Operating Margin	-23.53%
Pretax Margin	-15.13%
Profit Margin	-14.62%
EBITDA Margin	-8.69%
EBIT Margin	-23.53%
FCF Margin	n/a

Dividends & Yields

HKG:6185 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.66%
Shareholder Yield	1.66%
Earnings Yield	-0.97%
FCF Yield	-1.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:6185 has an Altman Z-Score of 3.12 and a Piotroski F-Score of 5.

Altman Z-Score	3.12
Piotroski F-Score	5